Which statement best describes perfusion-limited versus permeability-limited distribution and provides an example?

Which statement best describes perfusion-limited versus permeability-limited distribution and provides an example?

• A. Perfusion-limited distribution is controlled by membrane barriers requiring diffusion; permeability-limited distribution is driven by regional blood flow.
• B. Perfusion-limited distribution is controlled by regional blood flow and rapid tissue equilibration; permeability-limited distribution is controlled by membrane barriers requiring diffusion or transport; small, lipophilic drugs exemplify perfusion-limited; large polar drugs for permeability-limited.
• C. Both are the same mechanism; no difference; examples include anticoagulants.
• D. Perfusion-limited means slow distribution due to low blood flow; permeability-limited means fast diffusion.

Answer: (B)

The idea being tested is how the rate of drug distribution to tissues is limited either by blood flow or by the ability to cross tissue membranes. In perfusion-limited distribution, entry into the tissue is so rapid that the overall rate is governed by regional blood flow; once the drug reaches the tissue, it equilibrates quickly with plasma, so tissue and plasma concentrations track each other closely. Small, lipophilic drugs cross membranes readily, so their distribution into well-perfused tissues is limited mainly by how much blood is delivering the drug. In permeability-limited distribution, the barrier is the membrane or transport process itself. Even with good blood flow delivering the drug, crossing into the tissue is slow if the drug has poor permeability or must rely on transport mechanisms, so the distribution is limited by membrane barriers rather than by blood flow. Larger, polar drugs tend to show this behavior because their entry into tissues depends on diffusion through or transport across membranes. An example that fits this pattern is a small, lipophilic drug distributing quickly to highly perfused tissues—perfusion-limited. A large, polar drug, which struggles to cross membranes, would exhibit permeability-limited distribution. While other statements mix up what controls distribution or give incorrect generalizations (such as tying permeability limitation to blood flow or claiming both mechanisms are the same), this description aligns with the established distinction and the typical drug examples.

The idea being tested is how the rate of drug distribution to tissues is limited either by blood flow or by the ability to cross tissue membranes. In perfusion-limited distribution, entry into the tissue is so rapid that the overall rate is governed by regional blood flow; once the drug reaches the tissue, it equilibrates quickly with plasma, so tissue and plasma concentrations track each other closely. Small, lipophilic drugs cross membranes readily, so their distribution into well-perfused tissues is limited mainly by how much blood is delivering the drug.

In permeability-limited distribution, the barrier is the membrane or transport process itself. Even with good blood flow delivering the drug, crossing into the tissue is slow if the drug has poor permeability or must rely on transport mechanisms, so the distribution is limited by membrane barriers rather than by blood flow. Larger, polar drugs tend to show this behavior because their entry into tissues depends on diffusion through or transport across membranes.

An example that fits this pattern is a small, lipophilic drug distributing quickly to highly perfused tissues—perfusion-limited. A large, polar drug, which struggles to cross membranes, would exhibit permeability-limited distribution.

While other statements mix up what controls distribution or give incorrect generalizations (such as tying permeability limitation to blood flow or claiming both mechanisms are the same), this description aligns with the established distinction and the typical drug examples.